Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations

Journal of Immunology

Volumn 193, Issue 11, 2014, Pages 5626-5636

  Hill, Brenna J ^a   Darrah, Patricia A ^a   Ende, Zachary ^a   Ambrozak, David R ^a   Quinn, Kylie M ^a   Darko, Sam ^a   Gostick, Emma ^b   Wooldridge, Linda ^c   Van Den Berg, Hugo A ^d   Venturi, Vanessa ^e   Larsen, Martin ^f,g   Davenport, Miles P ^e   Seder, Robert A ^a   Price, David A ^a,b   Douek, Daniel C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Assistance publique Hôpitaux de Paris   (France)

^g SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EPITOPE; GAG PROTEIN; POL PROTEIN; VACCINE; H-2K(K) ANTIGEN; H2 ANTIGEN; H2D ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISSOCIATION; EPITOPE MAPPING; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; VACCINATION; ADENOVIRIDAE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; VIROLOGY;

ADENOVIRIDAE; AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENETIC VECTORS; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGEN H-2D; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED BALB C; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VACCINATION;

EID: 84912535413     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401017     Document Type: Article

References (81)

1. Lederman, M. M., G. Alter, D. C. Daskalakis, B. Rodriguez, S. F. Sieg, G. Hardy, M. Cho, D. Anthony, C. Harding, A. Weinberg, et al. 2010. Determinants of protection among HIV-exposed seronegative persons: an overview. J. Infect. Dis. 202(Suppl 3): S333-S338.
2. Tomescu, C., S. Abdulhaqq, and L. J. Montaner. 2011. Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin. Exp. Immunol. 164: 158-169.
3. Benjelloun, F., P. Lawrence, B. Verrier, C. Genin, and S. Paul. 2012. Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies. J. Virol. 86: 13152-13163.
4. Demers, K. R., M. A. Reuter, and M. R. Betts. 2013. CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis. Immunol. Rev. 254: 190-206.
5. Addo, M. M., X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77: 2081-2092.
6. Betts, M. R., D. R. Ambrozak, D. C. Douek, S. Bonhoeffer, J. M. Brenchley, J. P. Casazza, R. A. Koup, and L. J. Picker. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
7. Kiepiela, P., K. Ngumbela, C. Thobakgale, D. Ramduth, I. Honeyborne, E. Moodley, S. Reddy, C. de Pierres, Z. Mncube, N. Mkhwanazi, et al. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13: 46-53.
8. Rolland, M., D. Heckerman, W. Deng, C. M. Rousseau, H. Coovadia, K. Bishop, P. J. Goulder, B. D. Walker, C. Brander, and J. I. Mullins. 2008. Broad and Gagbiased HIV-1 epitope repertoires are associated with lower viral loads. PLoS ONE 3: e1424.
9. Kiepiela, P., A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale, S. Chetty, P. Rathnavalu, C. Moore, K. J. Pfafferott, L. Hilton, et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
10. Almeida, J. R., D. A. Price, L. Papagno, Z. A. Arkoub, D. Sauce, E. Bornstein, T. E. Asher, A. Samri, A. Schnuriger, I. Theodorou, et al. 2007. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204: 2473-2485.
11. Berger, C. T., N. Frahm, D. A. Price, B. Mothe, M. Ghebremichael, K. L. Hartman, L. M. Henry, J. M. Brenchley, L. E. Ruff, V. Venturi, et al. 2011. High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control. J. Virol. 85: 9334-9345.
12. Day, C. L., P. Kiepiela, A. J. Leslie, M. van der Stok, K. Nair, N. Ismail, I. Honeyborne, H. Crawford, H.M. Coovadia, P. J. Goulder, et al. 2007. Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection. J. Virol. 81: 434-438.
13. Migueles, S. A., A. C. Laborico, W. L. Shupert, M. S. Sabbaghian, R. Rabin, C. W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, et al. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.
14. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
15. Hersperger, A. R., F. Pereyra, M. Nason, K. Demers, P. Sheth, L. Y. Shin, C. M. Kovacs, B. Rodriguez, S. F. Sieg, L. Teixeira-Johnson, et al. 2010. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 6: e1000917.
16. Migueles, S. A., C. M. Osborne, C. Royce, A. A. Compton, R. P. Joshi, K. A. Weeks, J. E. Rood, A. M. Berkley, J. B. Sacha, N. A. Cogliano-Shutta, et al. 2008. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29: 1009-1021.
17. Blackbourn, D. J., C. E. Mackewicz, E. Barker, T. K. Hunt, B. Herndier, A. T. Haase, and J. A. Levy. 1996. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proc. Natl. Acad. Sci. USA 93: 13125-13130.
18. Sáez-Cirión, A., C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia, F. Boufassa, F. Barré-Sinoussi, J. F. Delfraissy, M. Sinet, G. Pancino, and A. Venet, Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. USA 104: 6776-6781.
19. Burgers, W. A., C. Riou, M. Mlotshwa, P. Maenetje, D. de Assis Rosa, J. Brenchley, K. Mlisana, D. C. Douek, R. Koup, M. Roederer, et al; CAPRISA 002 Acute Infection Study Team. 2009. Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J. Immunol. 182: 4751-4761.
20. Addo, M. M., R. Draenert, A. Rathod, C. L. Verrill, B. T. Davis, R. T. Gandhi, G. K. Robbins, N. O. Basgoz, D. R. Stone, D. E. Cohen, et al. 2007. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS ONE 2: e321.
21. Hess, C., M. Altfeld, S. Y. Thomas, M. M. Addo, E. S. Rosenberg, T. M. Allen, R. Draenert, R. L. Eldrige, J. van Lunzen, H. J. Stellbrink, et al. 2004. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet 363: 863-866.
22. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
23. Petrovas, C., J. P. Casazza, J. M. Brenchley, D. A. Price, E. Gostick, W. C. Adams, M. L. Precopio, T. Schacker, M. Roederer, D. C. Douek, and R. A. Koup. 2006. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
24. Trautmann, L., L. Janbazian, N. Chomont, E. A. Said, S. Gimmig, B. Bessette, M. R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
25. Yamamoto, T., D. A. Price, J. P. Casazza, G. Ferrari, M. Nason, P. K. Chattopadhyay, M. Roederer, E. Gostick, P. D. Katsikis, D. C. Douek, et al. 2011. Surface expression patterns of negative regulatory molecules identify determinants of virusspecific CD8+ T-cell exhaustion in HIV infection. Blood 117: 4805-4815.
26. Chen, H., Z. M. Ndhlovu, D. Liu, L. C. Porter, J. W. Fang, S. Darko, M. A. Brockman, T. Miura, Z. L. Brumme, A. Schneidewind, et al. 2012. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat. Immunol. 13: 691-700.
27. Ladell, K., M. Hashimoto, M. C. Iglesias, P. G.Wilmann, J. E. McLaren, S. Gras, T. Chikata, N. Kuse, S. Fastenackels, E. Gostick, et al. 2013. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 38: 425-436.
28. Appay, V., D. C. Douek, and D. A. Price. 2008. CD8+ T cell efficacy in vaccination and disease. Nat. Med. 14: 623-628.
29. Freel, S. A., K. O. Saunders, and G. D. Tomaras. 2011. CD8(+) T-cell-mediated control of HIV-1 and SIV infection. Immunol. Res. 49: 135-146.
30. Makedonas, G., and M. R. Betts. 2011. Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV. Immunol. Rev. 239: 109-124.
31. Butman, B. T., A. Lizonova, D. E. Brough, J. M. Sowers, R. Sheets, J. Gall, P. Newton, and P. Gomez. 2006. Comprehensive characterization of the 293-ORF6 cell line. Dev. Biol. (Basel) 123: 225-233, discussion 265-266.
32. Catanzaro, A. T., R. A. Koup, M. Roederer, R. T. Bailer, M. E. Enama, Z. Moodie, L. Gu, J. E. Martin, L. Novik, B. K. Chakrabarti, et al Vaccine Research Center 006 Study Team. 2006. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replicationdefective recombinant adenovirus vector. J. Infect. Dis. 194: 1638-1649.
33. Lindsay, R. W., P. A. Darrah, K. M. Quinn, U. Wille-Reece, L. M. Mattei, A. Iwasaki, S. P. Kasturi, B. Pulendran, J. G. Gall, A. G. Spies, and R. A. Seder. 2010. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J. Immunol. 185: 1513-1521.
34. Wille-Reece, U., B. J. Flynn, K. Loré, R. A. Koup, A. P. Miles, A. Saul, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder. 2006. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J. Exp. Med. 203: 1249-1258.
35. Darrah, P. A., S. T. Hegde, D. T. Patel, R. W. Lindsay, L. Chen, M. Roederer, and R. A. Seder. 2010. IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform. J. Exp. Med. 207: 1421-1433.
36. Darrah, P. A., D. T. Patel, P. M. De Luca, R.W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
37. Quinn, K. M., A. Da Costa, A. Yamamoto, D. Berry, R. W. Lindsay, P. A. Darrah, L. Wang, C. Cheng, W. P. Kong, J. G. Gall, et al. 2013. Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization. J. Immunol. 190: 2720-2735.
38. Chattopadhyay, P. K., D. A. Price, T. F. Harper, M. R. Betts, J. Yu, E. Gostick, S. P. Perfetto, P. Goepfert, R. A. Koup, S. C. De Rosa, et al. 2006. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat. Med. 12: 972-977.
39. Perfetto, S. P., P. K. Chattopadhyay, L. Lamoreaux, R. Nguyen, D. Ambrozak, R. A. Koup, and M. Roederer. 2006. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J. Immunol. Methods 313: 199-208.
40. Larsen, M., D. Sauce, L. Arnaud, S. Fastenackels, V. Appay, and G. Gorochov. 2012. Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS ONE 7: e42403.
41. Hahn, Y. S., A. Guanzon, C. M. Rice, and C. S. Hahn. 1999. Class I MHC molecule-mediated inhibition of Sindbis virus replication. J. Immunol. 162: 69-77.
42. Russ, G., M. Ramachandra, C. A. Hrycyna, M. M. Gottesman, I. Pastan, J. R. Bennink, and J. W. Yewdell. 1998. P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells. Cancer Res. 58: 4688-4693.
43. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, R. A. Koup, S. A. Migueles, E. Gostick, L. Wooldridge, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
44. Douek, D. C., M. R. Betts, J. M. Brenchley, B. J. Hill, D. R. Ambrozak, K. L. Ngai, N. J. Karandikar, J. P. Casazza, and R. A. Koup. 2002. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168: 3099-3104.
45. Quigley, M. F., J. R. Almeida, D. A. Price, and D. C. Douek. 2011. Unbiased molecular analysis of T cell receptor expression using template-switch anchored RT-PCR. Curr. Protoc. Immunol. Chapter 10: Unit 10.33.
46. Wong, P., and E. G. Pamer. 2003. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21: 29-70.
47. Venturi, V., K. Kedzierska, S. J. Turner, P. C. Doherty, and M. P. Davenport. 2007. Methods for comparing the diversity of samples of the T cell receptor repertoire. J. Immunol. Methods 321: 182-195.
48. Venturi, V., K. Kedzierska, M. M. Tanaka, S. J. Turner, P. C. Doherty, and M. P. Davenport. 2008. Method for assessing the similarity between subsets of the T cell receptor repertoire. J. Immunol. Methods 329: 67-80.
49. Yousfi Monod, M., V. Giudicelli, D. Chaume, and M. P. Lefranc. 2004. IMGT/ JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 20(Suppl 1): i379-i385.
50. Hoffmeister, B., F. Kiecker, L. Tesfa, H. D. Volk, L. J. Picker, and F. Kern. 2003. Mapping T cell epitopes by flow cytometry. Methods 29: 270-281.
51. Maecker, H. T., H. S. Dunn, M. A. Suni, E. Khatamzas, C. J. Pitcher, T. Bunde, N. Persaud,W. Trigona, T. M. Fu, E. Sinclair, et al. 2001. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255: 27-40.
52. Precopio, M. L., T. R. Butterfield, J. P. Casazza, S. J. Little, D. D. Richman, R. A. Koup, and M. Roederer. 2008. Optimizing peptide matrices for identifying T-cell antigens. Cytometry A 73: 1071-1078.
53. Doe, B., and C. M. Walker. 1996. HIV-1 p24 Gag-specific cytotoxic Tlymphocyte responses in mice. AIDS 10: 793-794.
54. Miles, J. J., D. C. Douek, and D. A. Price. 2011. Bias in the ab T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol. Cell Biol. 89: 375-387.
55. Lichterfeld, M., X. G. Yu, S. K.Mui, K. L.Williams, A. Trocha, M. A. Brockman, R. L. Allgaier, M. T. Waring, T. Koibuchi, M. N. Johnston, et al. 2007. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J. Virol. 81: 4199-4214.
56. Quigley, M. F., H. Y. Greenaway, V. Venturi, R. Lindsay, K. M. Quinn, R. A. Seder, D. C. Douek, M. P. Davenport, and D. A. Price. 2010. Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. Proc. Natl. Acad. Sci. USA 107: 19414-19419.
57. Venturi, V., D. A. Price, D. C. Douek, and M. P. Davenport. 2008. The molecular basis for public T-cell responses? Nat. Rev. Immunol. 8: 231-238.
58. Venturi, V., M. F. Quigley, H. Y. Greenaway, P. C. Ng, Z. S. Ende, T. McIntosh, T. E. Asher, J. R. Almeida, S. Levy, D. A. Price, et al. 2011. A mechanism for TCR sharing between T cell subsets and individuals revealed by pyrosequencing. J. Immunol. 186: 4285-4294.
59. La Gruta, N. L., W. T. Rothwell, T. Cukalac, N. G. Swan, S. A. Valkenburg, K. Kedzierska, P. G. Thomas, P. C. Doherty, and S. J. Turner. 2010. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J. Clin. Invest. 120: 1885-1894.
60. Moon, J. J., H. H. Chu, M. Pepper, S. J. McSorley, S. C. Jameson, R. M. Kedl, and M. K. Jenkins. 2007. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
61. Ruckwardt, T. J., A. M. Malloy, E. Gostick, D. A. Price, P. Dash, J. L. McClaren, P. G. Thomas, and B. S. Graham. 2011. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. PLoS Pathog. 7: e1002377.
62. Laugel, B., H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell. 2007. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282: 23799-23810.
63. Sun, Y., S. Santra, J. E. Schmitz, M. Roederer, and N. L. Letvin. 2008. Magnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeys. J. Virol. 82: 8812-8819.
64. Choi, E. Y., G. J. Christianson, Y. Yoshimura, T. J. Sproule, N. Jung, S. Joyce, and D. C. Roopenian. 2002. Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. Immunity 17: 593-603.
65. Kotturi, M. F., I. Scott, T. Wolfe, B. Peters, J. Sidney, H. Cheroutre, M. G. von Herrath, M. J. Buchmeier, H. Grey, and A. Sette. 2008. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J. Immunol. 181: 2124-2133.
66. La Gruta, N. L., K. Kedzierska, K. Pang, R. Webby, M. Davenport, W. Chen, S. J. Turner, and P. C. Doherty. 2006. A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. USA 103: 994-999.
67. Obar, J. J., K. M. Khanna, and L. Lefrançois. 2008. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 28: 859-869.
68. Schmidt, J., C. Neumann-Haefelin, T. Altay, E. Gostick, D. A. Price, V. Lohmann, H. E. Blum, and R. Thimme. 2011. Immunodominance of HLAA2-restricted hepatitis C virus-specific CD8+ T cell responses is linked to naiveprecursor frequency. J. Virol. 85: 5232-5236.
69. Tan, A. C., N. L. La Gruta, W. Zeng, and D. C. Jackson. 2011. Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice. J. Immunol. 187: 1895-1902.
70. Miconnet, I., A. Marrau, A. Farina, P. Taffé, S. Vigano, A. Harari, and G. Pantaleo. 2011. Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure. J. Immunol. 186: 7039-7049.
71. La Gruta, N. L., P. G. Thomas, A. I. Webb, M. A. Dunstone, T. Cukalac, P. C. Doherty, A. W. Purcell, J. Rossjohn, and S. J. Turner. 2008. Epitope-specific TCRbeta repertoire diversity imparts no functional advantage on the CD8+ T cell response to cognate viral peptides. Proc. Natl. Acad. Sci. USA 105: 2034-2039.
72. Moffat, J. M., A. Handel, P. C. Doherty, S. J. Turner, P. G. Thomas, and N. L. La Gruta. 2010. Influenza epitope-specific CD8+ T cell avidity, but not cytokine polyfunctionality, can be determined by TCRb clonotype. J. Immunol. 185: 6850-6856.
73. Price, D. A., T. E. Asher, N. A. Wilson, M. C. Nason, J. M. Brenchley, I. S. Metzler, V. Venturi, E. Gostick, P. K. Chattopadhyay, M. Roederer, et al. 2009. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J. Exp. Med. 206: 923-936.
74. Almeida, J. R., D. Sauce, D. A. Price, L. Papagno, S. Y. Shin, A. Moris, M. Larsen, G. Pancino, D. C. Douek, B. Autran, et al. 2009. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113: 6351-6360.
75. Iglesias, M. C., J. R. Almeida, S. Fastenackels, D. J. van Bockel, M. Hashimoto, V. Venturi, E. Gostick, A. Urrutia, L. Wooldridge, M. Clement, et al. 2011. Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood 118: 2138-2149.
76. Chattopadhyay, P. K., M. R. Betts, D. A. Price, E. Gostick, H. Horton, M. Roederer, and S. C. De Rosa. 2009. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 85: 88-97.
77. Takata, H., and M. Takiguchi. 2006. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J. Immunol. 177: 4330-4340.
78. Wolint, P., M. R. Betts, R. A. Koup, and A. Oxenius. 2004. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J. Exp. Med. 199: 925-936.
79. Peperzak, V., Y. Xiao, E. A. Veraar, and J. Borst. 2010. CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J. Clin. Invest. 120: 168-178.
80. Precopio, M. L., M. R. Betts, J. Parrino, D. A. Price, E. Gostick, D. R. Ambrozak, T. E. Asher, D. C. Douek, A. Harari, G. Pantaleo, et al. 2007. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204: 1405-1416.
81. Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640.